Literature DB >> 15235042

The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features.

R F Badenhop1, J C Jansen, P A Fagan, R S A Lord, Z G Wang, W J Foster, P R Schofield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15235042      PMCID： PMC1735850          DOI： 10.1136/jmg.2003.011551

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  19 in total

1.  The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.

Authors:  Guillaume Gravel; Patricia Niccoli; Vincent Rohmer; Guy Moulin; Françoise Borson-Chazot; Pascal Rousset; Anne Pasco-Papon; Claude Marcus; Frédérique Dubrulle; Hervé Gouya; François Bidault; Benoit Dupas; Jean Gabrillargues; Aurore Caumont-Prim; Anne Hernigou; Anne-Paule Gimenez-Roqueplo; Philippe Halimi
Journal:  Eur Radiol       Date:  2015-10-01       Impact factor: 5.315

Review 2.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

3.  Age and Tumor Volume Predict Growth of Carotid and Vagal Body Paragangliomas.

Authors:  Berdine L Heesterman; Lisa M H de Pont; Berit M Verbist; Andel G L van der Mey; Eleonora P M Corssmit; Frederik J Hes; Peter Paul G van Benthem; Jeroen C Jansen
Journal:  J Neurol Surg B Skull Base       Date:  2017-07-31

4.  Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1.

Authors:  Franciele B Leidenz; Luciana Bastos-Rodrigues; Marcelo Oliveira; Marcelo Mamede; Marta Sarquis; Eitan Friedman; Luiz de Marco
Journal:  Genet Res (Camb)       Date:  2015-03-30       Impact factor: 1.588

5.  Phenotype of SDHB mutation carriers in the Netherlands.

Authors:  Leonie T van Hulsteijn; Nienke D Niemeijer; Frederik J Hes; Jean-Pierre Bayley; Carli M Tops; Jeroen C Jansen; Eleonora P M Corssmit
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

Review 6.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

Review 7.  Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC).

Authors:  Ulrich Müller
Journal:  Neurogenetics       Date:  2011-03-09       Impact factor: 2.660

8.  Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.

Authors:  Mariola Peczkowska; Zoran Erlic; Michael M Hoffmann; Mariusz Furmanek; Jaroslaw Cwikla; Agata Kubaszek; Aleksander Prejbisz; Zbigniew Szutkowski; Andrzej Kawecki; Krzysztof Chojnowski; Anna Lewczuk; Mieczyslaw Litwin; Witold Szyfter; Martin A Walter; Maren Sullivan; Charis Eng; Andrzej Januszewicz; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

Review 9.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.

Authors:  Jin-Qiang Chen; Patrick R Cammarata; Christopher P Baines; James D Yager
Journal:  Biochim Biophys Acta       Date:  2009-06-23

Review 10.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.